Pharnext (OTCMKTS:PNEXF) Trading Up 399,999,900% – Still a Buy?

Pharnext SA (OTCMKTS:PNEXF)’s share price was up 399,999,900% during trading on Monday . The stock traded as high as $400.00 and last traded at $400.00. Approximately 16,660 shares were traded during mid-day trading, an increase of 3,748% from the average daily volume of 433 shares. The stock had previously closed at $0.00.

Pharnext Stock Performance

The business’s fifty day simple moving average is $400.00 and its 200-day simple moving average is $400.00.

Pharnext Company Profile

Pharnext SA, a clinical-stage biopharmaceutical company, engages in the development of therapies for neurodegenerative diseases with high unmet medical needs. Its products include PXT3003, a novel fixed-dose synergistic combination of baclofen, naltrexone, and sorbitol formulated that is in Phase III clinical trials for the treatment of Charcot-Marie-tooth disease type 1A; and PXT864 to treat amyotrophic lateral sclerosis.